Biotech
Ginkgo Bioworks, Inc.
1
Articles
Primary Subject
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
2.15
Relevance Score
Coverage Timeline
April 2026
2026 BIOSECURE Act: How Tougher Biosafety Rules Are Forcing Biotech Investors to Rethink Risk
Policy
Primary Subject
Apr 11, 2026
Ginkgo Bioworks’ Q2 2025 earnings call, with its 30% year-over-year jump in biosafety compliance expenses, turned out to be the canary in the coal mine for the entire sector.